Navigation Links
The Leukemia & Lymphoma Society and Women's Running Magazine Join Forces to Launch New All-Women Half Marathon in St. Petersburg
Date:2/5/2009

City officials grant permission today for the event to take place November 21-22

WHITE PLAINS, N.Y. and ST. PETERSBURG, Fla., Feb. 5 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and Women's Running magazine laud St. Petersburg city officials' announcement today granting the two organizations permission to produce an all women's half marathon the weekend of November 21-22, 2009.

The event, Women's Running St. Pete Half Marathon to benefit The Leukemia & Lymphoma Society, will draw women from across the country. It will be St. Petersburg's first women only half marathon. Participants can train to run or walk the half marathon through LLS's Team In Training (TNT), the world's first, largest and best charity sports training program. With TNT, participants join a group of supportive teammates and get four to five months of training with certified coaches, and in return, they raise funds to support blood cancer research and patient services.

"We're excited to partner with The Leukemia & Lymphoma Society's Team In Training," said Dawna Stone, President and Founder of Women's Running magazine. "Together I believe we can grow the St. Pete Women's Half Marathon into the premier women's half marathon."

The flat, fast race course will wind along the science downtown St. Petersburg waterfront, through quaint communities, past historic buildings and museums.

"The Leukemia & Lymphoma Society wants to thank the officials of St. Petersburg for granting us the opportunity to put on this great event," said Nancy Klein, Chief Marketing and Revenue Officer of LLS. "This will be an exciting weekend, giving participants the chance to take on an athletic challenge while also making a difference in the lives of thousands of people fighting blood cancer."

About The Leukemia & Lymphoma Society

The L
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Leukemia stem cells have more in common with embryonic stem cells than adult stem cells
2. St. Jude finds more than 100 gene variations linked with response to leukemia treatment
3. In Kids, Genes May Affect Leukemia Treatment
4. New study aims to reduce risk of childhood leukemia
5. Hard-to-Treat Leukemia Cell Subtype Identified
6. Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
7. Childhood Leukemia Subtype Resists Treatment
8. Gene Governs Response to Leukemia Chemotherapy
9. Gene abnormality found to predict childhood leukemia relapse
10. The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
11. Grape Seed Extract Kills Leukemia Cells in Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Department of Energy has selected a Texas Wind Integration project ... to conduct a regional smart grid demonstration project. Drummond Group,s ... leading the testing efforts with strong support from the project ... ... (PRWEB) December 7, 2009 -- The Department of Energy ...
(Date:12/7/2009)... partners with Cure to support medical research. , ... ... its part to help find a cure for spinal cord injury: ... Catheters to its list of nearly 45,000 products., , ,Cure Medical ... facilitate finding a cure for spinal cord injury, the company donates ...
(Date:12/7/2009)... Dec. 7 Cell Therapeutics, Inc. ("CTI") ... Pettengell, M.D. of St. George,s Hospital, University of ... Society of Hematology ("ASH") Annual Meeting updated results ... clinical trial of pixantrone (the "PIX 301 EXTEND ... ("NHL") patients who have failed 2 or ...
(Date:12/6/2009)... Ill., Dec. 7 The University HealthSystem ... members for their achievements in UHC,s Supply Chain ... are noted for modeling best practices in supply ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined using ... includes contract portfolio participation and use of UHC ...
(Date:12/6/2009)... in Cambridge have discovered that the loss of a key ... is the first study to show that this kind of ... in Nature . , The study, led by Dr ... Hurles from the Wellcome Trust Sanger Institute, looked at 300 ... entire genome looking for types of mutation known as copy ...
Breaking Medicine News(10 mins):Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 2Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 3Health News:Drummond Group Awarded DOE Funds for Texas Wind Integration Project 4Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 2Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 3Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 4Health News:Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkin's Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data 5Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2
... SHENZHEN, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International ... manufacturer,and marketer of medical devices worldwide, today announced ... a Mindray company, Mr.,Cheng Minghe, Mindray,s executive vice ... Li, Mindray,s investor relations manager, will hold,a conference ...
... the key to better understanding the effect addictive drugs have ... breakthrough study, Design Logic of a Cannabinoid Receptor Signaling Network ... on May 16th, 2008. , The research findings give ... to better understand the role addictive drugs have on the ...
... first FDA-approved nebulized formoterol fumarate ... NAPA, Calif., May 16 Dey, L.P. announced today ... International,Conference of the American Thoracic Society (ATS) on May ... the presentations details the,effects on dyspnea and other COPD ...
... Adding a second monoclonal antibody drug to chemotherapy looks ... to Mayo Clinic researchers working with the North Central ... this interim analysis were released May 15 as part ... of Clinical Oncology. , Researchers found that 95 ...
... coincides with increased use of MRI before surgeries, researchers ... After years of declining rates, the number of mastectomies ... rise again, the Mayo Clinic now reports. ... resonance imaging (MRI) before surgery, according to the authors, ...
... IRVINE, Calif., May 16 IDM Pharma, Inc.,(Nasdaq: ... presentations evaluating,the Company,s lead product candidates will be ... Oncology (ASCO) annual meeting. Data presented,at the meeting ... treated with L-MTP-PE, as well as patients with ...
Other Medicine News:Health News:Mindray to Hold Conference Call to Discuss the Integration Plan and Closing of the Acquisition of Datascope Corp.'s Patient Monitoring Business 2Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 2Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 3Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 4Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 5Health News:Adding epratuzumab to standard therapy 2Health News:Mastectomies on the Increase 2Health News:Mastectomies on the Increase 3Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 3
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... developers of the AcceleDent System , which ... the availability of a new Continuing Education course ... in professional education for many industries, including medicine ... views about orthodontic treatment, a summary of treatment ...
(Date:12/4/2009)... Care today announced the three grand prize winners of Bayer,s ... Jonas Brothers, selected the winning video entries submitted by children ... an in-person meeting today with Nick. ,, The ... age 6, from Danbury, CT, who dreams of becoming a ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Universal Health Services Inc Announces Stock Split and Cash Dividend Increase 61672 1Healthy Feet Make the Best Dancing Feet 61667 1Healthy Feet Make the Best Dancing Feet 61667 2Vernier and Bio Rad to Offer Enhanced Solutions for Biotechnology Education 14908 1Vernier and Bio Rad to Offer Enhanced Solutions for Biotechnology Education 14908 2
... at American Association for Cancer Research meeting ... of non-water-soluble drugs to treat cancer and ... Celator Pharmaceuticals today,reported results on a novel ... dissolving in water (hydrophobic drugs) in nanoparticles to,enhance ...
... The,Foundation for Cancer Research and Education (FCRE) announced today ... will,lecture on new treatments for prostate cancer at Westminster ... AM--12:30 PM., "With the recent press around prostate ... says. "The good news is there are many,things people ...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles 'Snuffy' Myers Announces Vitamin D Clinical Trials 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: